What are the guidelines for administering sodium bicarbonate (NaHCO3) 150mEq intravenous (IV) push?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sodium Bicarbonate 150mEq IV Push: Administration Guidelines

Critical Safety Warning

Do not administer 150mEq of sodium bicarbonate as a rapid IV push—this dose is dangerously high and can cause life-threatening complications including severe hypernatremia, hyperosmolarity, cerebral edema, and death. 1

Standard Dosing for IV Push Administration

Adults and Adolescents

  • Initial bolus: 1-2 mEq/kg (typically 50-100 mEq for a 70kg adult) administered slowly 2, 3, 4
  • Maximum safe single bolus: Do not exceed 6 mEq/kg total cumulative dose to avoid hypernatremia, fluid overload, metabolic alkalosis, and cerebral edema 1
  • For a 70kg adult, this translates to approximately 70-140 mEq as initial dose, with maximum cumulative dose of 420 mEq 1

Pediatric Patients

  • 1-2 mEq/kg IV given slowly 2, 3
  • Newborn infants: Use only 0.5 mEq/mL (4.2%) concentration; dilute 8.4% solution 1:1 with normal saline or sterile water 2, 3
  • Children <2 years: Dilute 8.4% solution 1:1 with normal saline to achieve 4.2% concentration 3

Concentration and Preparation

Standard Concentrations

  • 8.4% solution (1 mEq/mL): Can be used undiluted in adults and children ≥2 years, though dilution is often performed for safety 3, 4
  • 4.2% solution (0.5 mEq/mL): Required for newborns and children <2 years 2, 3

Why 150mEq Push is Dangerous

  • A 150mEq bolus represents 2-3 times the recommended maximum single dose for most adults 3, 1
  • Hypertonic bicarbonate (8.4% = 2000 mOsm/L) causes severe hyperosmolarity when given rapidly in large volumes 4, 1
  • Exceeding 6 mEq/kg cumulative dose commonly causes hypernatremia (Na+ >150-155 mEq/L), fluid overload, and potentially lethal cerebral edema 3, 5, 1

Specific Clinical Indications

When Sodium Bicarbonate is Indicated

Sodium Channel Blocker/Tricyclic Antidepressant Toxicity (Class I Indication)

  • 1-2 mEq/kg bolus for life-threatening cardiotoxicity with QRS >120ms 3, 1
  • Target serum pH 7.45-7.55, not QRS normalization 1
  • Administer with hyperventilation (PCO2 30-35 mmHg) to achieve synergistic alkalinization 1
  • Repeat boluses as needed up to maximum 6 mEq/kg cumulative dose 1

Severe Hyperkalemia

  • 1-2 mEq/kg IV push to shift potassium intracellularly 2, 3
  • Must be combined with glucose/insulin, not used as monotherapy 3
  • Do not administer through same line as calcium gluconate 2

Documented Severe Metabolic Acidosis (pH <7.1)

  • Only after effective ventilation established 2, 3
  • Initial dose: 1-2 mEq/kg given slowly 2, 3, 4
  • Repeat dosing guided by arterial blood gas, not empirically 3, 4

When Sodium Bicarbonate is NOT Indicated

Cardiac Arrest (Routine Use)

  • Not recommended for routine use in cardiac arrest 2, 3
  • May consider only after first epinephrine dose ineffective, with documented severe acidosis, or in hyperkalemia/sodium channel blocker-related arrest 3

Lactic Acidosis from Hypoperfusion (pH ≥7.15)

  • Explicitly contraindicated by Surviving Sepsis Campaign 3, 6
  • No improvement in hemodynamics or vasopressor requirements demonstrated 3
  • Causes sodium/fluid overload, increased lactate production, increased PCO2, and decreased ionized calcium 3

Diabetic Ketoacidosis (pH ≥7.0)

  • Not necessary and may cause harm, especially in pediatric patients 3, 6
  • Consider only if pH <6.9: 50-100 mmol in 200-400mL sterile water infused at 200mL/h 3

Administration Technique

Rate of Administration

  • "Given slowly" means over several minutes, NOT rapid push 2, 4
  • In cardiac arrest: May give more rapidly (one to two 50mL vials over 5-10 minutes) 4
  • For metabolic acidosis: Administer over 4-8 hours as infusion, not bolus 4

IV Line Compatibility

  • Never mix with calcium-containing solutions (causes precipitation) 2, 3
  • Never mix with vasoactive amines (causes inactivation) 2, 3
  • Flush line with normal saline before and after bicarbonate administration 3
  • Use separate IV line from blood products 7

Monitoring Requirements

Essential Laboratory Monitoring

  • Arterial blood gases every 2-4 hours to assess pH, PaCO2, and bicarbonate response 3, 4
  • Serum sodium every 2-4 hours initially: Target <150-155 mEq/L 3, 5
  • Serum potassium frequently: Alkalemia causes hypokalemia via intracellular shift 3, 5, 1
  • Ionized calcium: Bicarbonate decreases ionized calcium 3, 1

Target Parameters

  • pH: 7.45-7.55 (not >7.55 to avoid excessive alkalemia) 3, 1
  • Serum sodium: <150-155 mEq/L 3, 5
  • Avoid complete correction of acidosis in first 24 hours: Target total CO2 ~20 mEq/L initially 4

Adverse Effects and Complications

Immediate Complications from Excessive Dosing

  • Severe hypernatremia (Na+ >155 mEq/L) 3, 5, 1
  • Hyperosmolarity with compromised cerebral perfusion 3, 4
  • Cerebral edema (potentially fatal) 1
  • Fluid overload in patients with cardiac/renal dysfunction 4, 8

Metabolic Complications

  • Hypokalemia from intracellular potassium shift during alkalemia 3, 5, 1
  • Ionized hypocalcemia affecting cardiac contractility 3, 1
  • Rebound metabolic alkalosis 4, 8
  • Paradoxical intracellular acidosis from excess CO2 production 3, 8

Cardiovascular Complications

  • QT prolongation and torsades de pointes in mixed sodium/potassium channel blocker toxicity (e.g., hydroxychloroquine, flecainide) when combined with hypokalemia/hypocalcemia 1
  • Inactivation of simultaneously administered catecholamines 2, 3
  • Left shift of oxyhemoglobin curve inhibiting oxygen release 3

Correct Approach for 150mEq Dose

If 150mEq sodium bicarbonate is truly indicated (rare), it must be administered as a continuous infusion, not IV push:

Infusion Protocol

  • Dilute 150 mEq NaHCO3 in 1 liter of solution (creates isotonic or near-isotonic solution) 3
  • Infuse over 4-8 hours minimum, not as bolus 4
  • Used for sodium channel blocker overdose maintenance: "150 mEq NaHCO3/L solution at 1-3 mL/kg/h" 3
  • Requires continuous cardiac monitoring and frequent laboratory assessment 4, 1

Clinical Algorithm for Decision-Making

Step 1: Identify the specific indication

  • Sodium channel blocker toxicity with QRS >120ms or ventricular dysrhythmia? → Bolus 1-2 mEq/kg 3, 1
  • Severe hyperkalemia with ECG changes? → Bolus 1-2 mEq/kg with glucose/insulin 2, 3
  • Severe metabolic acidosis pH <7.1 with adequate ventilation? → Bolus 1-2 mEq/kg 2, 3
  • Lactic acidosis pH ≥7.15? → Do not give bicarbonate 3, 6

Step 2: Calculate appropriate dose

  • Weight-based: 1-2 mEq/kg (typically 50-100 mEq for average adult) 2, 3
  • Never exceed 6 mEq/kg cumulative dose 1

Step 3: Prepare correct concentration

  • Adults/children ≥2 years: 8.4% can be used 3
  • Children <2 years: Dilute to 4.2% 3
  • Newborns: Must use 4.2% 2, 3

Step 4: Administer slowly with monitoring

  • Give over several minutes, not rapid push 2, 4
  • Flush line before and after 3
  • Monitor cardiac rhythm continuously 1

Step 5: Reassess with laboratory values

  • Check ABG, electrolytes, ionized calcium within 30-60 minutes 3, 4
  • Repeat dosing only if pH remains <7.45 and patient unstable 1
  • Stop if pH >7.55, Na+ >155 mEq/L, or clinical improvement 3, 5, 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sodium Bicarbonate Infusion for Acidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Administration of Sodium Tablets in Patients Taking Sodium Bicarbonate

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A Review of Bicarbonate Use in Common Clinical Scenarios.

The Journal of emergency medicine, 2023

Guideline

Administration of Sodium Bicarbonate During Blood Infusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.